FDA approves CSL hemophilia gene therapy - BioProcess Insider

With a list price of $3.5 million, Hemgenix becomes the most expensive single-dose drug and the first gene therapy approved for hemophilia B.

Related Keywords

Australia ,Massachusetts ,United States ,Kim Phelan ,Drug Administration ,Coalition For Hemophiliab Over ,